BlackRock Institutional Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$12.3M Buy
5,819,729
+718,707
+14% +$1.52M ﹤0.01% 2285
2016
Q3
$17.1M Sell
5,101,022
-72,002
-1% -$241K ﹤0.01% 1994
2016
Q2
$16.2M Buy
5,173,024
+250,137
+5% +$785K ﹤0.01% 1979
2016
Q1
$16.4M Buy
4,922,887
+238,586
+5% +$794K ﹤0.01% 1944
2015
Q4
$16.6M Buy
4,684,301
+109,337
+2% +$387K ﹤0.01% 1988
2015
Q3
$23M Sell
4,574,964
-40,578
-0.9% -$204K ﹤0.01% 1740
2015
Q2
$29.7M Sell
4,615,542
-45,884
-1% -$295K ﹤0.01% 1638
2015
Q1
$32.8M Buy
4,661,426
+100,109
+2% +$704K 0.01% 1598
2014
Q4
$35.2M Sell
4,561,317
-3,507
-0.1% -$27K 0.01% 1528
2014
Q3
$34.1M Sell
4,564,824
-47,359
-1% -$354K 0.01% 1523
2014
Q2
$44.6M Sell
4,612,183
-40,926
-0.9% -$396K 0.01% 1389
2014
Q1
$38.7M Buy
4,653,109
+269,073
+6% +$2.24M 0.01% 1480
2013
Q4
$37M Buy
4,384,036
+15,215
+0.3% +$128K 0.01% 1486
2013
Q3
$34.8M Sell
4,368,821
-87,039
-2% -$694K 0.01% 1444
2013
Q2
$34.4M Buy
+4,455,860
New +$34.4M 0.01% 1403